Penserra Capital Management LLC Jounce Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$7.11 - $9.64 $8,318 - $11,278	-1,170 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.04 - $8.73 $25 - $43	5 Added 0.43%	1,170 $8,000
Q2 2021 Aug 12, 2021	BUY	$6.58 - $10.66 $888 - $1,439	135 Added 13.11%	1,165 $7,000
Q1 2021 May 13, 2021	BUY	$6.73 - $13.87 $572 - $1,178	85 Added 8.99%	1,030 $10,000
Q4 2020 Feb 12, 2021	BUY	$6.37 - $10.33 $6,019 - $9,761	945 New	945 $6,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.